Close Menu

NEW YORK — Canadian health data company Avricore Health said on Tuesday that it has signed a letter of intent to work with Avrok Laboratories to offer rapid SARS-CoV-2 antigen testing for international travelers.

Avrok, which operates a CLIA-certified lab in California, will oversee the testing of travelers in Canada, the US, Mexico, and the Caribbean, for example at resorts and through airlines. The test results will then be reported directly via Avricore's HealthTab point-of-care screening and test result management platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.